| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 699667 | Null | 0.0220039422291539 | 0.07603998 |
| NSC 707904 | Null | 0.0220039422291539 | 0.35380487 |
| NSC 708390 | Null | 0.0220039422291539 | 0.32625324 |
| NSC 714379 | Null | 0.0220039422291539 | -0.038569432 |
| NSC 720299 | Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane | 0.0220039422291539 | 0.19798084 |
| NSC 722854 | 1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline | 0.0220039422291539 | 0.13089939 |
| NSC 727087 | 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate | 0.0220039422291539 | 0.096607909 |
| NSC 733504 | Everolimus | 0.0220039422291539 | -0.1147968 |
| NSC 737757 | 2-(4-((oxiran-2-yl)methoxy)styryl)-4,5-dihydrooxazole | 0.0220039422291539 | 0.18060685 |
| NSC 763059 | Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride | 0.0220039422291539 | 0.073328527 |